Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyu Chen

Showing results (531-540 of 537) with videos related to

Pageof 54
Sort By:
You have reached the last page of results.This site can display upto 537 results.
The Lancet. Respiratory Medicine|June 1, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Chunlan Zhuang, Kai Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusionXiao Zhang, Junping Hong, Ling Zhong, et al.
Medical Image Analysis|June 26, 2026
Beyond the LUMIR challenge: The pathway to foundational registration modelsJunyu Chen, Shuwen Wei, Joel Honkamaa, et al.
Science Bulletin|May 31, 2022
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
The Lancet. Respiratory Medicine|November 18, 2023
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
Nature Biomedical Engineering|October 24, 2025
Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infectionsTingting Li, Wenhui Xue, Sibo Zhang, et al.
Nature Communications|July 11, 2023
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamstersLiang Zhang, Yao Jiang, Jinhang He, et al.
Pageof 54

Showing results (531-540 of 537) with videos related to

Sort By:
Pageof 54
You have reached the last page of results.This site can display upto 537 results.
The Lancet. Respiratory Medicine|June 1, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Chunlan Zhuang, Kai Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusionXiao Zhang, Junping Hong, Ling Zhong, et al.
Medical Image Analysis|June 26, 2026
Beyond the LUMIR challenge: The pathway to foundational registration modelsJunyu Chen, Shuwen Wei, Joel Honkamaa, et al.
Science Bulletin|May 31, 2022
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
The Lancet. Respiratory Medicine|November 18, 2023
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
Nature Biomedical Engineering|October 24, 2025
Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infectionsTingting Li, Wenhui Xue, Sibo Zhang, et al.
Nature Communications|July 11, 2023
Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamstersLiang Zhang, Yao Jiang, Jinhang He, et al.
Pageof 54